Trial Outcomes & Findings for A Clinical Trial Comparing Laser TURP With and Without Dutasteride. (NCT NCT00431626)

Results Overview

AUA symptoms index change is measured on a five level-scale: -2 (much worse), -1(worse) , 0 (no change), 1 (better), 2 (much better)

Recruitment status

TERMINATED

Study phase

PHASE3

Target enrollment

4 participants

Primary outcome timeframe

one year

Results posted on

2015-10-28

Withdrawal data not reported

A Clinical Trial Comparing Laser TURP With and Without Dutasteride.

Baseline characteristics by cohort
Measure	Laser TURP With Dutasteride n=4 Participants Prior to and after standard treatment with laser TURP, dutasteride is applied to each patient Dutasteride (Avodart)	Laser TURP With Placebo Prior to and after standard treatment with laser TURP, placebo is applied to each patient	Total n=4 Participants Total of all reporting groups
Age, Continuous	47 years STANDARD_DEVIATION 12 • n=5 Participants	—	47 years STANDARD_DEVIATION 12 • n=5 Participants
Gender Female	0 participants n=5 Participants	—	0 participants n=5 Participants
Gender Male	4 participants n=5 Participants	—	4 participants n=5 Participants

Timeframe: one year

AUA symptoms index change is measured on a five level-scale: -2 (much worse), -1(worse) , 0 (no change), 1 (better), 2 (much better)

Outcome measures
Measure	Laser TURP With Dutasteride n=4 Participants Prior to and after standard treatment with laser TURP, dutasteride is applied to each patient Dutasteride (Avodart)	Laser TURP With Placebo Prior to and after standard treatment with laser TURP, placebo is applied to each patient
Primary Outcome Measure Will be the 5 Point Change in AUA Symptom Index	1 units on a scale Standard Deviation 0.8	—

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Adverse event data not reported

Adverse event data not reported

Northwestern U

Phone: 312 503 2008